Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025)
Shattuck Labs (STTK) reported Asset Writedowns and Impairment of $81000.0 for Q4 2025, up 8.0% year-over-year from $75000.0 in Q4 2024, and up 8.0% on a QoQ basis from $75000.0 in Q4 2024.
Shattuck Labs (STTK) has 4 years of Asset Writedowns and Impairment data on file, last reported at $81000.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment rose 8.0% year-over-year to $81000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $156000.0 (down 58.73% YoY) and the FY2025 annual result came in at $81000.0, down 63.51% from the prior year.
- Asset Writedowns and Impairment improved to $81000.0 in Q4 2025 per STTK's latest filing, from $75000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $400000.0 in Q2 2022 and bottomed at $75000.0 in Q4 2024.
- The 4-year median for Asset Writedowns and Impairment is $151500.0 (2023), against an average of $209833.3.
- The widest annual swing landed in 2023, when Asset Writedowns and Impairment plunged 49.0%; it then grew 8.0% in 2025.
- Tracing STTK's Asset Writedowns and Impairment over 4 years: stood at $400000.0 in 2022, then slumped by 75.25% to $99000.0 in 2023, then declined by 24.24% to $75000.0 in 2024, then increased by 8.0% to $81000.0 in 2025.
- Per Business Quant, the three latest STTK Asset Writedowns and Impairment figures stand at $81000.0 (Q4 2025), $75000.0 (Q4 2024), and $99000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Shattuck Labs | 667.80 Mn | 667.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |